Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160 USD | -1.03% | -4.35% | +3.25% |
30/04 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
29/04 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.25% | 286B | |
+31.33% | 699B | |
+25.07% | 571B | |
-4.22% | 364B | |
+18.53% | 326B | |
+14.49% | 236B | |
+4.58% | 198B | |
-12.47% | 194B | |
-4.46% | 154B | |
-3.51% | 149B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie : Mizuho Securities Adjusts AbbVie's Price Target to $128 From $126, Maintains Buy Rating